Transient transfection of siRNA targetting beta-catenin was performed using DreamFect reagent in ovarian cancer cell line.
This article demonstrate the versatility of Dreamfect transfection reagent from OZ Biosciences to efficiently deliver siRNA into SKOV3 cell line.article reference: FASEB J. 2013 May 2.
Tissue transglutaminase regulates β-catenin signaling through a c-Src-dependent mechanism.Abstract
Tissue transglutaminase
(TG2) is a multifunctional enzyme involved in protein cross-linking and
cell adhesion to fibronectin (FN). In cancer, TG2 induces an epithelial
to mesenchymal transition, contributing to metastasis. Because
cadherins bind β-catenin at cell-cell junctions, disruption of adherens junctions destabilizes cadherin-catenin complexes. The goal of the present study was to analyze whether and how TG2 interacts with and regulates β-catenin signaling in ovarian cancer (OC) cells. We observed a significant correlation between TG2 and β-catenin expression levels in OC cells and tumors. TG2 augmented Wnt/β-catenin signaling, as evidenced by enhanced β-catenin
transcriptional activity, inducing transcription of target genes cyclin
D1 and c-Myc. By promoting integrin-mediated cell adhesion to FN, TG2
physically associates with and recruits c-Src, which in turn
phosphorylates β-catenin at Tyr654,
releasing it from E-cadherin and rendering it available for
transcriptional regulation. By interacting with FN and enhancing β-catenin signaling, complexed TG2 stimulates OC cell proliferation. In summary, our data demonstrate that TG2 regulates β-catenin expression and function in OC cells and define the c-Src-dependent mechanism through which this occurs.-Condello, S., Cao, L., Matei, D. Tissue transglutaminase regulates β-catenin signaling through a c-Src-dependent mechanism.
No comments:
Post a Comment